
View larger version (114K):
[in this window]
[in a new window]
|
Fig. 3. Embryonic loss-of-function phenotypes of mib2 alleles.
(A-C) Lateral views of the ventral region of stage 16 wild-type (A),
mib21 (B) and mib21 (C) germline clone
Drosophila embryos stained with anti-myosin (A,B) or anti-Tropomyosin
(C). Positions of VA2, VT1 and VO muscles are indicated. Note the presence of
unfused myoblasts (black arrowheads in B,C), the absence of muscles in the VL
region (asterisks in B,C, and muscle scheme in
Fig. 4G), and presence of
myospheres (arrow, B). Whole-embryo pictures (below) are focused on the gut.
White arrowheads point to the position of the first midgut constriction (A)
and to the unfolded midgut (B,C). (D,E) Dorsal views focused on
the DA1 muscle of mib21/CyO and mib21
stage 15 embryos, respectively. Arrowheads point to Eve-labelled nuclei
(green). Asterisks mark nuclei of pericardial cells. (F) Number of
eve-expressing nuclei in DA1 muscles of embryos of the indicated
genotype (n, number of hemisegments quantified). (G-J)
Progressive degeneration of muscles in mib21 embryos.
Muscles were revealed by Mhc- -GFP (G,I,J) and by
anti-Tm staining (H). At stage 15 (H), all muscles are present and attached to
the apodemes (arrowhead, unfused myoblast). At stage 16 (I), some muscle
attachments are becoming thinner (arrowhead), while others, many in the VL
region, have detached (arrows). In L1 larvae, most muscles are missing (J).
(K) Scheme indicating percentages of specific muscles that remain
attached to apodemes in mib21 first instar larvae: red
(80-100%), blue (50-80%), yellow (10-25%) and white (<10%) (n=50
abdominal hemisegments; 2 to 5 examined).
|